Truvestments Capital LLC Akari Therapeutics PLC Transaction History

Truvestments Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.41 - $12.8 $252 - $7,884	-616 Reduced 38.0%	1,005 $0
Q2 2022 Aug 09, 2022	BUY	$0.95 - $1.22 $1,539 - $1,977	1,621 New	1,621 $2,000
Q1 2022 May 02, 2022	SELL	$1.09 - $1.53 $1,766 - $2,480	-1,621 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$1.81 - $3.88 $948 - $2,033	-524 Reduced 24.43%	1,621 $4,000
Q4 2020 Feb 17, 2021	BUY	$1.5 - $2.02 $3,217 - $4,332	2,145 New	2,145 $3,000
Q3 2020 Nov 13, 2020	SELL	$1.58 - $2.37 $3,389 - $5,083	-2,145 Closed	0 $0
Q2 2020 Aug 06, 2020	BUY	$1.16 - $2.61 $2,488 - $5,598	2,145 New	2,145 $4,000
Q4 2019 Jan 29, 2020	SELL	$1.69 - $2.16 $6,139 - $7,847	-3,633 Closed	0 $0
Q3 2019 Oct 10, 2019	SELL	$1.69 - $2.92 $539 - $931	-319 Reduced 8.07%	3,633 $6,000
Q1 2019 Apr 12, 2019	SELL	$1.66 - $5.9 $282 - $1,003	-170 Reduced 4.12%	3,952 $14,000
Q3 2018 Oct 22, 2018	BUY	$1.82 - $2.56 $7,502 - $10,552	4,122 New	4,122 $11,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $68.8M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Truvestments Capital LLC with notifications on news.